12月24日泰格医药股价涨5.27%，报53.72元/股，成交3.47亿元，总市值462.54亿元。该公司2004年成立，2012年上市，主营为医药及健康产品研发提供专业临床研究服务，临床试验相关服务及实验室服务、临床试验技术服务分别占主营业务收入的52.60%、45.21%。诺安基金旗下4只基金重仓泰格医药，合计持有414.27万股，日浮盈1114.39万元，其中诺安先锋混合A持有最多，浮盈约...
Source Link12月24日泰格医药股价涨5.27%，报53.72元/股，成交3.47亿元，总市值462.54亿元。该公司2004年成立，2012年上市，主营为医药及健康产品研发提供专业临床研究服务，临床试验相关服务及实验室服务、临床试验技术服务分别占主营业务收入的52.60%、45.21%。诺安基金旗下4只基金重仓泰格医药，合计持有414.27万股，日浮盈1114.39万元，其中诺安先锋混合A持有最多，浮盈约...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.